The Radiotherapy Market encompasses a broad range of equipment, software, treatment systems, and services used to deliver radiation-based therapies for cancer and other clinical applications. The market includes external beam radiotherapy, brachytherapy, systemic radiotherapy, intensity-modulated radiotherapy, image-guided radiotherapy, stereotactic radiosurgery, and other advanced treatment technologies.
Radiotherapy remains an important component of modern oncology because radiation can be used across curative, postoperative, preoperative, and palliative treatment settings. Increasing cancer incidence, expanding oncology infrastructure, technological advancements, and growing adoption of precision treatment approaches are supporting market development.
The global Radiotherapy Market closed 2025 at approximately USD 9.09 billion and is projected to reach USD 18.91 billion by 2035, representing a CAGR of 7.6% during 2026–2035, according to the latest Market Research Future report.
Get Free Sample PDF Brochure:
Radiotherapy Market Sample Request: https://www.marketresearchfuture.com/sample_request/1526
Market Drivers
Rising Global Cancer Incidence
The increasing incidence of cancer is one of the major factors driving demand for radiotherapy technologies. As cancer patient volumes increase, healthcare providers require additional radiation treatment capacity, advanced linear accelerators, treatment-planning systems, and supporting imaging technologies.
Technological Advancements
Continuous innovation in radiotherapy is improving treatment precision and workflow efficiency. Intensity-modulated radiotherapy, image-guided radiotherapy, stereotactic technologies, adaptive treatment planning, and advanced treatment-management software are expanding the capabilities of radiation oncology departments.
Increasing Demand for Personalized Treatment
Healthcare providers are increasingly adopting treatment approaches that can be tailored to individual patient anatomy, tumor characteristics, and treatment objectives. Advanced imaging, treatment planning, and adaptive radiotherapy technologies can support more precise radiation delivery.
Adoption of Artificial Intelligence
Artificial intelligence and machine learning are increasingly being incorporated into treatment planning, image analysis, auto-segmentation, workflow optimization, and adaptive radiotherapy. AI-assisted tools can reduce manual workload and potentially improve treatment-planning efficiency.
Expansion of Oncology Infrastructure
Healthcare systems in emerging economies are investing in cancer treatment infrastructure, including radiation therapy centers, linear accelerators, treatment-planning systems, and specialized oncology facilities. Expansion of treatment capacity is creating opportunities for equipment and technology suppliers.
Growing Outpatient Radiotherapy
The movement of selected radiation treatments toward outpatient settings and the adoption of shorter treatment courses can increase treatment-center capacity. Hypofractionation can allow providers to treat selected patients using fewer sessions while improving utilization of existing treatment infrastructure.
Market Challenges
High Capital Investment
Radiotherapy infrastructure requires substantial investment in treatment equipment, radiation-shielded facilities, treatment-planning software, imaging systems, maintenance, and trained personnel. High capital requirements can limit adoption in smaller hospitals and developing healthcare systems.
Shortage of Skilled Professionals
Radiotherapy requires radiation oncologists, medical physicists, radiation therapists, dosimetrists, engineers, and other trained professionals. Shortages of qualified personnel can restrict the effective deployment and utilization of advanced radiation treatment systems.
Regulatory Requirements
Radiotherapy equipment and radiation-related technologies are subject to strict safety, quality, and regulatory requirements. Compliance with regulations can increase development, installation, certification, and operational costs.
Complex Infrastructure Requirements
Linear accelerators and other sophisticated radiotherapy systems require specialized facilities, radiation shielding, imaging capabilities, power infrastructure, maintenance, and quality-control systems. Construction and regulatory approval can extend installation timelines.
Radioisotope Supply Constraints
Brachytherapy and systemic radiotherapy applications may depend on reliable supplies of medical radioisotopes. Supply-chain disruptions and limited production capacity for certain isotopes can create operational challenges for treatment centers.
Browse In-depth Market Research Report on Radiotherapy Market:
Radiotherapy Market Research Report: https://www.marketresearchfuture.com/reports/radiotherapy-market-1526
Market Segmentation
By Product:
Radiotherapy Equipment: Radiotherapy equipment represents the largest product category and includes linear accelerators, treatment delivery systems, imaging equipment, brachytherapy systems, and other radiation treatment platforms. Fleet replacement and new treatment-center installations are important demand drivers.
Radiotherapy Software: Treatment-planning and oncology software support treatment design, dose calculation, image processing, treatment management, adaptive planning, and workflow optimization. AI-assisted planning and auto-segmentation are creating additional opportunities.
Radiotherapy Services: Services include equipment maintenance, technical support, applications support, software upgrades, training, and managed-service arrangements. Recurring service revenue is becoming increasingly important as healthcare providers seek predictable operating costs.
By Technology:
External Beam Radiotherapy: External beam radiotherapy delivers radiation from a source outside the patient’s body and is widely used for numerous cancer indications.
Brachytherapy: Brachytherapy involves placing radioactive sources close to or inside the treatment area. It is commonly used in selected cancers, including cervical and prostate cancers.
Systemic Radiotherapy: Systemic radiotherapy uses radioactive substances that travel through the body or target specific biological mechanisms. Growing radiopharmaceutical applications are supporting this segment.
Intensity-Modulated Radiotherapy: IMRT allows radiation intensity to be varied across treatment fields to improve dose conformity and help protect surrounding healthy tissue. IMRT accounted for 33.9% of market share in 2025 according to MRFR.
Image-Guided Radiotherapy: IGRT integrates imaging with treatment delivery to improve positioning and account for changes in patient anatomy and tumor location.
Stereotactic Radiosurgery: Stereotactic technologies deliver highly focused radiation to selected targets and are increasingly used for appropriate cranial and extracranial indications.
Proton Beam Therapy: Proton therapy uses charged particles and can provide highly localized dose distributions for selected patients. MRFR projects proton beam therapy to grow at approximately 9.0% CAGR through 2035.
By Application:
Oncology: Oncology represents the primary application of radiotherapy, covering treatment of a broad range of solid tumors.
Palliative Care: Radiation can be used to relieve symptoms associated with advanced cancer, including pain and other tumor-related complications.
Preoperative Treatment: Radiotherapy may be used before surgery for selected cancer types to reduce tumor size or improve treatment outcomes.
Postoperative Treatment: Postoperative radiation can help manage residual microscopic disease and reduce recurrence risk in appropriate clinical situations.
Curative Treatment: Radiotherapy can be used with curative intent either alone or in combination with surgery and systemic therapies depending on the cancer type and treatment plan.
By End User:
Hospitals: Hospitals represent a major end-user segment because they provide comprehensive oncology services and typically have the infrastructure required for advanced radiotherapy systems.
Cancer Research Centers: Cancer research centers support clinical research, treatment innovation, technology evaluation, and advanced radiation oncology programs.
Outpatient Facilities: Outpatient radiotherapy facilities are expanding as shorter treatment courses and advanced treatment workflows improve the feasibility of ambulatory care.
Specialized Cancer Centers: Dedicated cancer centers provide integrated oncology services and frequently invest in advanced radiation treatment platforms and supporting technologies.
By Treatment Type:
Conventional Radiotherapy: Conventional radiotherapy includes established radiation treatment approaches used across a wide range of cancer indications.
Radiotherapy for Targeted Therapy: Targeted radiotherapy approaches combine radiation delivery with increasingly precise biological targeting strategies.
Combination Therapy: Combination therapy integrates radiotherapy with treatments such as chemotherapy, immunotherapy, targeted therapies, or other oncology interventions.
Regional Insights
North America
North America represents the largest regional market for radiotherapy. The region benefits from advanced healthcare infrastructure, high cancer treatment demand, established reimbursement systems, significant research investment, and widespread availability of advanced radiation oncology technologies. North America accounted for approximately 44.4% of global revenue in 2025 according to MRFR.
Europe
Europe represents another major radiotherapy market supported by established cancer-care systems, technological development, research institutions, and government investment in oncology infrastructure. The region generated approximately USD 2.44 billion in radiotherapy revenue in 2025.
Asia-Pacific
Asia-Pacific is expected to be one of the fastest-growing regions during the forecast period. Increasing cancer incidence, expanding healthcare infrastructure, government cancer-control programs, and increasing installation of radiation treatment systems are contributing to regional growth. MRFR projects the Asia-Pacific region to expand at approximately 9.6% CAGR through 2035.
South America
South America presents growth opportunities as healthcare systems expand cancer treatment capacity and increase investment in modern radiotherapy infrastructure. Demand for linear accelerators, treatment-planning systems, and oncology services can support market development.
Middle East & Africa
The Middle East and Africa represent developing radiotherapy markets. Investment in healthcare infrastructure, cancer-care programs, medical technology, and specialized oncology facilities can support increased access to radiation therapy.
Key Players
The competitive landscape includes major radiotherapy equipment, medical technology, imaging, software, and healthcare companies. Key participants include:
- Varian Medical Systems
- Elekta AB
- Accuray Incorporated
- Siemens Healthineers
- Philips Healthcare
- GE Healthcare
- Hitachi Ltd.
- CIVCO Medical Solutions
- Brainlab AG
These companies compete through technological innovation, product development, software integration, service offerings, partnerships, and expansion of radiation oncology solutions.
Future Outlook
The Radiotherapy Market is expected to continue expanding as the global burden of cancer increases and healthcare systems invest in additional treatment capacity. The market is projected to reach approximately USD 18.91 billion by 2035, growing at a 7.6% CAGR from 2026 to 2035 according to the latest MRFR report.
Artificial intelligence is expected to become increasingly important in treatment planning, auto-segmentation, adaptive radiotherapy, image analysis, and workflow management. These technologies can help radiation oncology departments improve efficiency and utilize existing treatment infrastructure more effectively.
Another important trend is the shift toward shorter treatment courses and outpatient care. Hypofractionated treatment approaches can reduce the number of patient visits and potentially increase treatment-center capacity for selected indications.
Asia-Pacific is expected to provide significant growth opportunities because of expanding oncology infrastructure and increasing investment in cancer treatment. Emerging markets may also benefit from international initiatives and financing programs designed to improve access to radiation therapy.
The convergence of external beam radiotherapy with nuclear medicine and targeted radiopharmaceutical approaches is expected to create additional opportunities. At the same time, service contracts, software upgrades, adaptive planning, AI solutions, and managed-service models may become increasingly important sources of recurring revenue.
Overall, rising cancer incidence, technological innovation, personalized treatment, AI integration, expansion of outpatient radiotherapy, and increasing investment in emerging healthcare markets are expected to support the long-term development of the global radiotherapy industry.
Related Reports:
About Market Research Future:
Market Research Future (MRFR) is a global market research company providing market research and consulting services across healthcare, medical devices, pharmaceuticals, technology, and other industries. Its research covers market trends, technologies, applications, end users, competitive landscapes, regional markets, and growth opportunities.
Its research helps organizations understand market dynamics, identify emerging opportunities, evaluate competition, and support strategic business decisions.
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
